In order to help pathologists evaluate the severity of the disease, AI algorithms can categorize breast cancer subtypes (e.g., estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-positive) and provide tumor grades. This evidence concerns the gene ERBB2 and breast carcinoma.